![5 VCs discuss the future of SaaS and software after Pfizer’s vaccine breakthrough – TechCrunch]()
by Our Source | Jan 3, 2021 | Startups
SaaS stocks sold sharply on good vaccine tidings, but do VCs care? Monday’s news that a COVID-19 vaccine candidate looks to be incredibly effective gave investors reasons to believe in a better future. Perhaps COVID-19 won’t be with us for years, investors appeared to...
![5 VCs discuss the future of SaaS and software after Pfizer’s vaccine breakthrough – TechCrunch]()
by Our Source | Jan 3, 2021 | Startups
Accelerators have become a major force in the startup world, but these teeming masses of potential have been forced, like every other industry, to adopt major changes with the pandemic. Surprisingly, however, they have not just rolled with the punches but seem to be...
![5 VCs discuss the future of SaaS and software after Pfizer’s vaccine breakthrough – TechCrunch]()
by Our Source | Jan 3, 2021 | Startups
Andy Areitio is a partner at the early-stage fund TheVentureCity, a new venture and acceleration model that helps diverse founders achieve global impact. When you’re running your own venture — especially if it’s your first — it’s unlikely you will find the time to...
![5 VCs discuss the future of SaaS and software after Pfizer’s vaccine breakthrough – TechCrunch]()
by Our Source | Jan 3, 2021 | Startups
If you’re a part of the early-stage startup space race, or aspire to such celestial heights, don’t miss out on early-bird savings to TC Sessions: Space 2020 on December 16-17. We’re at T-minus four days and counting — buy your pass before the countdown clock strikes...
![5 VCs discuss the future of SaaS and software after Pfizer’s vaccine breakthrough – TechCrunch]()
by Our Source | Jan 3, 2021 | Startups
French startup Molotov provides a TV streaming service in France that replaces the traditional set-top box. You can access live TV, subscribe to premium channels, watch content after they air and record content in the cloud. Today, the company is launching a different...
![5 VCs discuss the future of SaaS and software after Pfizer’s vaccine breakthrough – TechCrunch]()
by Our Source | Jan 3, 2021 | Startups
Fishtown Analytics, the Philadelphia-based company behind the dbt open-source data engineering tool, today announced that it has raised a $29.5 million Series B round led by Sequoia Captial, with participation from previous investors Andreessen Horowitz and Amplify...
Recent Comments